Literature DB >> 6325451

Phosphorylase phosphatase. Interconversion of active and inactive forms.

E Villa-Moruzzi, L M Ballou, E H Fischer.   

Abstract

Phosphorylase phosphatase is isolated as an inactive Mr = 70,000 complex made up of a catalytic and a regulatory subunit (inhibitor 2). Separation of the two components yields the free catalytic subunit in a completely inactive state. It can be activated by Mn2+ or Co2+, not Mg2+ or Ca2+. No metal ion is incorporated during this process, as shown by the use of 54Mn2+. The inactive complex, but not the isolated catalytic subunit, can be activated by the protein kinase FA (Vandenheede, J.R., Yang, S.-D., Goris, J., and Merlevede, W. (1980) J. Biol. Chem. 255, 11768-11774), which causes the simultaneous phosphorylation of inhibitor 2 and conversion of the catalytic subunit to an active conformation. The activated enzyme undergoes autodephosphorylation to produce a complex that is inactive even though the catalytic subunit is still in the active form; in a slower step, it returns to its original inactive state. No such conversion occurs in the absence of inhibitor 2, indicating that the regulatory subunit is required for both the activation and inactivation reactions. Complexes were prepared by adding inhibitor 2 to various isolated catalytic subunits. Only the one reconstituted with the FA-activated species behaved like the native enzyme in that the catalytic subunit underwent transformation to the inactive form, then could be reactivated by FA. These data suggest that the two subunits must interact in a highly specific manner to allow the structural changes accompanying the activation-inactivation process. Models are proposed for the changes in conformation induced by Mn2+ or FA.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6325451

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Identification of the ATP.Mg-dependent protein phosphatase activator (FA) as a synapsin I kinase that inhibits cross-linking of synapsin I with brain microtubules.

Authors:  S D Yang; J S Song; Y T Hsieh; H W Liu; W H Chan
Journal:  J Protein Chem       Date:  1992-10

2.  Regulation of protein phosphatase 1I by Cdc25C-associated kinase 1 (C-TAK1) and PFTAIRE protein kinase.

Authors:  Jimcy Platholi; Anna Federman; Julia A Detert; Paul Heerdt; Hugh C Hemmings
Journal:  J Biol Chem       Date:  2014-07-15       Impact factor: 5.157

3.  Identification and partial characterization of a latent ATP, Mg-dependent protein phosphatase in rabbit skeletal muscle cytosol.

Authors:  J R Vandenheede; S Staquet; W Merlevede
Journal:  Mol Cell Biochem       Date:  1989-05-04       Impact factor: 3.396

4.  Stimulation of protein phosphatase activity by insulin and growth factors in 3T3 cells.

Authors:  C P Chan; S J McNall; E G Krebs; E H Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

5.  Phosphorylation and inactivation of protein phosphatase 1 by pp60v-src.

Authors:  J W Johansen; T S Ingebritsen
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

6.  On the mechanism of activation of protein kinase FA (an activating factor of ATP.Mg-dependent protein phosphatase) in brain myelin.

Authors:  S D Yang; J S Yu; C W Hua
Journal:  J Protein Chem       Date:  1990-02

7.  Inhibition of the Mg(II).ATP-dependent phosphoprotein phosphatase by the regulatory subunit of cAMP-dependent protein kinase.

Authors:  S R Jurgensen; P B Chock; S Taylor; J R Vandenheede; W Merlevede
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

8.  Regulation of chromosome segregation by Glc8p, a structural homolog of mammalian inhibitor 2 that functions as both an activator and an inhibitor of yeast protein phosphatase 1.

Authors:  H Y Tung; W Wang; C S Chan
Journal:  Mol Cell Biol       Date:  1995-11       Impact factor: 4.272

9.  Obg-like ATPase 1 regulates global protein serine/threonine phosphorylation in cancer cells by suppressing the GSK3β-inhibitor 2-PP1 positive feedback loop.

Authors:  Dong Xu; Renduo Song; Guohui Wang; Prince V S Jeyabal; Amanda M Weiskoff; Kefeng Ding; Zheng-Zheng Shi
Journal:  Oncotarget       Date:  2016-01-19
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.